2 mins read

BrightEdge’s Impact: Transforming Cancer Care and Changing Lives

In a groundbreaking move to revolutionize cancer care and treatment, BrightEdge LLC, the venture capital and impact investment arm of the American Cancer Society (ACS), has unveiled its annual report. The report outlines how the organization’s investment portfolio, consisting of 18 diverse companies, stands poised to positively impact the lives of more than 1.5 million cancer patients and their families. This remarkable achievement is underpinned by BrightEdge’s proprietary Cancer Impact Investing

1 2 3 235

Follow Us